bpc 157 human clinical trial 2025 BPC-157: What the Science Says (Zero Trials) bpc-157 clinical trial human 2025

In the years immediately following the IOMs 1998 report setting the current RDA, research associated an abnormally high level of homocysteine, a molecule involved in protein metabolism, with an increased risk of cardiovascular disease, mortality, and cognitive impairment

Continued preclinical investigation will be necessary to clarify its mechanisms and determine what, if anything, this research model can reveal about broader tissue repair biology.

For in vivo or ex vivo studies (if employed in nonclinical contexts), consider potential biodistribution, clearance, and off-target interactions in experimental design

It is intended solely for laboratory experimentation and in vitro studies